Age-related differences in neuroinflammatory responses associated with a distinct profile of regulatory markers on neonatal microglia

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Christensen, Leah B ^a   Woods, Tyson A ^a   Carmody, Aaron B ^a   Caughey, Byron ^a   Peterson, Karin E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD172A ANTIGEN; CELL MARKER; CELL PROTEIN; CYTOKINE; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; REGULATOR PROTEIN; SLAMF7 PROTEIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CPG-OLIGONUCLEOTIDE; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LIPOPOLYSACCHARIDE; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; OLIGODEOXYRIBONUCLEOTIDE; POLY(2-ACRYLAMIDO-2-METHYL-1-PROPANESULFONIC ACID); POLYMER; PTPNS1 PROTEIN, MOUSE; SULFONIC ACID DERIVATIVE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN DEVELOPMENT; BRAIN LEVEL; CELL ACTIVATION; CELL LEVEL; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; GROUPS BY AGE; IMMUNE RESPONSE; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; PERINATAL CARE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STIMULUS RESPONSE; UPREGULATION; AGING; ANIMAL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; INFLAMMATION; METABOLISM; TOXICITY;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11A; ANTIGENS, DIFFERENTIATION; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; POLYMERS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SULFONIC ACIDS; TOLL-LIKE RECEPTORS;

EID: 84898037632     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-70     Document Type: Article

References (54)

1. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005, 162:767-773. 10.1176/appi.ajp.162.4.767, 15800151.
2. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000, 13:133-139. 10.1097/00019052-200004000-00004, 10987569.
3. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull 2009, 35:631-637. 10.1093/schbul/sbn121, 2669577, 18832344.
4. Chen GH, Wang H, Yang QG, Tao F, Wang C, Xu DX. Acceleration of age-related learning and memory decline in middle-aged CD-1 mice due to maternal exposure to lipopolysaccharide during late pregnancy. Behav Brain Res 2011, 218:267-279. 10.1016/j.bbr.2010.11.001, 21070822.
5. Ling Z, Zhu Y, Tong C, Snyder JA, Lipton JW, Carvey PM. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol 2006, 199:499-512. 10.1016/j.expneurol.2006.01.010, 16504177.
6. Wang S, Yan JY, Lo YK, Carvey PM, Ling Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res 2009, 1265:196-204.
7. Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009, 3:14. 2737431, 19738918.
8. Gilmore JH, Jarskog LF. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 1997, 24:365-367. 10.1016/S0920-9964(96)00123-5, 9134598.
9. Clancy B, Darlington RB, Finlay BL. Translating developmental time across mammalian species. Neuroscience 2001, 105:7-17. 10.1016/S0306-4522(01)00171-3, 11483296.
10. Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937. 10.1016/j.neuro.2007.01.014, 2077812, 17368774.
11. Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079. 10.1016/j.neubiorev.2009.05.001, 19442688.
12. Belderbos ME, Van Bleek GM, Levy O, Blanken MO, Houben ML, Schuijff L, Kimpen JL, Bont L. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009, 133:228-237. 10.1016/j.clim.2009.07.003, 2892115, 19648060.
13. Pedraza-Sanchez S, Hise AG, Ramachandra L, Arechavaleta-Velasco F, King CL. Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns. Clin Vaccine Immunol 2013, 20:962-971. 10.1128/CVI.00609-12, 3697450, 23595503.
14. Liao SL, Yeh KW, Lai SH, Lee WI, Huang JL. Maturation of Toll-like receptor 1-4 responsiveness during early life. Early Hum Dev 2013, 89:473-478. 10.1016/j.earlhumdev.2013.03.013, 23591080.
15. Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A, Harnois M, Merindol N, Herblot S, Duval M. Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol 2012, 276:114-121. 10.1016/j.cellimm.2012.04.010, 22578600.
16. Burl S, Townend J, Njie-Jobe J, Cox M, Adetifa UJ, Touray E, Philbin VJ, Mancuso C, Kampmann B, Whittle H, Jaye A, Flanagan KL, Levy O. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One 2011, 6:e18185. 10.1371/journal.pone.0018185, 3076452, 21533209.
17. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 2011, 12:189-194.
18. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004, 173:4627-4634.
19. De WD, Tonon S, Olislagers V, Goriely S, Boutriaux M, Goldman M, Willems F. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003, 21:277-281. 10.1016/j.jaut.2003.08.003, 14599853.
20. Ghosh A, Streit WJ, Minghetti L, Basu A. Microglia in development and disease. Clin Dev Immunol 2013, 2013:736459. 3771266, 24078818.
21. Harry GJ. Microglia during development and aging. Pharmacol Ther 2013, 139:313-326. 10.1016/j.pharmthera.2013.04.013, 23644076.
22. Lewis S. Development: microglia go pruning. Nat Rev Neurosci 2011, 12:492-493.
23. Alliot F, Godin I, Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 1999, 117:145-152. 10.1016/S0165-3806(99)00113-3, 10567732.
24. Lewis SD, Butchi NB, Khaleduzzaman M, Morgan TW, Du M, Pourciau S, Baker DG, Akira S, Peterson KE. Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation. J Neurovirol 2008, 14:492-502. 10.1080/13550280802345723, 19016073.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
26. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
27. Peterson KE, Evans LH, Wehrly K, Chesebro B. Increased proinflammatory cytokine and chemokine responses and microglial infection following inoculation with neural stem cells infected with polytropic murine retroviruses. Virology 2006, 354:143-153. 10.1016/j.virol.2006.06.016, 16875710.
28. Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 2010, 58:650-664. 3767435, 19998480.
29. Butchi NB, Pourciau S, Du M, Morgan TW, Peterson KE. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists. J Immunol 2008, 180:7604-7612.
30. Butchi NB, Woods T, Du M, Morgan TW, Peterson KE. TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS. Am J Pathol 2011, 179:783-794. 10.1016/j.ajpath.2011.04.011, 3157277, 21801870.
31. Tassi I, Colonna M. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells. J Immunol 2005, 175:7996-8002.
32. Veillette A. NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol Rev 2006, 214:22-34. 10.1111/j.1600-065X.2006.00453.x, 17100873.
33. Campanella M, Sciorati C, Tarozzo G, Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 2002, 33:586-592. 10.1161/hs0202.103399, 11823674.
34. Wang XJ, Ye M, Zhang YH, Chen SD. CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol 2007, 2:259-264. 10.1007/s11481-007-9075-1, 18040859.
35. Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation 2011, 8:24. 10.1186/1742-2094-8-24, 3068094, 21401967.
36. Satoh J, Lee YB, Kim SU. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res 1995, 704:92-96. 10.1016/0006-8993(95)01177-3, 8750966.
37. Moneta ME, Gehrmann J, Topper R, Banati RB, Kreutzberg GW. Cell adhesion molecule expression in the regenerating rat facial nucleus. J Neuroimmunol 1993, 45:203-206. 10.1016/0165-5728(93)90181-W, 8101190.
38. Boles KS, Barten R, Kumaresan PR, Trowsdale J, Mathew PA. Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics 1999, 50:1-7. 10.1007/s002510050679, 10541800.
39. Kim JR, Horton NC, Mathew SO, Mathew PA. CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes. Inflamm Res 2013, 62:765-772. 10.1007/s00011-013-0632-1, 23695528.
40. Chelvarajan L, Popa D, Liu Y, Getchell TV, Stromberg AJ, Bondada S. Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages. J Leukoc Biol 2007, 82:403-416. 10.1189/jlb.0107071, 17495050.
41. Chelvarajan RL, Collins SM, Doubinskaia IE, Goes S, Van WJ, Flanagan D, De Villiers WJ, Bryson JS, Bondada S. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J Leukoc Biol 2004, 75:982-994. 10.1189/jlb.0403179, 14982942.
42. Clancy B, Kersh B, Hyde J, Darlington RB, Anand KJ, Finlay BL. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007, 5:79-94.
43. Meuth SG, Simon OJ, Grimm A, Melzer N, Herrmann AM, Spitzer P, Landgraf P, Wiendl H. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J Neuroimmunol 2008, 194:62-69. 10.1016/j.jneuroim.2007.11.013, 18164423.
44. Zhang S, Wang XJ, Tian LP, Pan J, Lu GQ, Zhang YJ, Ding JQ, Chen SD. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J Neuroinflammation 2011, 8:154. 10.1186/1742-2094-8-154, 3226566, 22053982.
45. Liu DQ, Li LM, Guo YL, Bai R, Wang C, Bian Z, Zhang CY, Zen K. Signal regulatory protein alpha negatively regulates beta2 integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis. PLoS One 2008, 3:e3291. 10.1371/journal.pone.0003291, 2553263, 18820737.
46. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 2010, 11:734-742. 10.1038/ni.1908, 20639876.
47. Scott MJ, Billiar TR. Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 2008, 283:29433-29446. 10.1074/jbc.M803905200, 2570897, 18701460.
48. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ. Growth control of cultured microglia. J Neurosci Res 1992, 33:218-230. 10.1002/jnr.490330205, 1333539.
49. Holm TH, Draeby D, Owens T. Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia 2012, 60:630-638. 10.1002/glia.22296, 22271465.
50. Krasowska-Zoladek A, Banaszewska M, Kraszpulski M, Konat GW. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J Neurosci Res 2007, 85:205-212. 10.1002/jnr.21088, 17061254.
51. Bushong EA, Martone ME, Ellisman MH. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int J Dev Neurosci 2004, 22:73-86. 10.1016/j.ijdevneu.2003.12.008, 15036382.
52. Freeman MR. Specification and morphogenesis of astrocytes. Science 2010, 330:774-778. 10.1126/science.1190928, 21051628.
53. Antony JM, Paquin A, Nutt SL, Kaplan DR, Miller FD. Endogenous microglia regulate development of embryonic cortical precursor cells. J Neurosci Res 2011, 89:286-298. 10.1002/jnr.22533, 21259316.
54. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010, 166:464-475. 10.1016/j.neuroscience.2009.12.040, 20035837.